CLSA analyst David Dong reiterated an Outperform (2) rating and CHF135.00 price target on Novartis (NOVN:SW) (NYSE: NVS).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE